NCT03246607View on ClinicalTrials.gov

Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 26, 2020

Primary Completion Date

August 2, 2020

Study Completion Date

October 1, 2020

Conditions
Traumatic Brain InjuryAcquired Brain InjuryIntracerebral HemorrhageSubarachnoid HemorrhageIschemic Stroke
Interventions
DEVICE

MicroEye & ContinuMon

Continuous intravascular glucose monitoring using MicroEye/ContinuMon system, peripherally inserted via a peripheral venous catheter.

Trial Locations (1)

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Sponsors

Collaborators (1)

Probe Scientific Limited
All Listed Sponsors
collaborator

Probe Scientific Limited

INDUSTRY

lead

Dr Andrew Stevens

OTHER